Fractal Spectrum of a Quasi_periodically Driven Spin System

We numerically perform a spectral analysis of a quasi-periodically driven spin 1/2 system, the spectrum of which is Singular Continuous. We compute fractal dimensions of spectral measures and discuss their connections with the time behaviour of various dynamical quantities, such as the moments of the distribution of the wave packet. Our data suggest a close similarity between the information dimension of the spectrum and the exponent ruling the algebraic growth of the 'entropic width' of wavepackets.Comment: 17 pages, RevTex, 5 figs. available on request from [email protected]

Improving the early diagnosis of early nodular melanoma: can we do better?

Introduction: Cutaneous melanoma is the sixth most common malignant cancer in the USA. Among different subtypes of melanoma, nodular melanoma (NM) accounts about 14% of all cases but is responsible for more than 40% of melanoma deaths. Early diagnosis is the best method to improve melanoma prognosis. Unfortunately, early diagnosis of NM is particularly challenging given that patients often lack identifiable risk factors such as many moles or freckles. Moreover, early NM may mimic a range of benign skin lesions that are not routinely excised or biopsied in every day practice. For this reason, specific clinical and skin imaging clues have been proposed to improve early detection of NM.Areas covered: The review discusses about the noninvasive tools to diagnose thin melanoma, particularly NM. Expert commentary: Currently, dermatologists present a wide opportunity of diagnostic tools. Current data suggest that the early diagnosis of NM is a major challenge as the majority of early NM are symmetric, roundish, and lack specific pattern. Another promising strategy is based on recent data suggesting that artificial intelligence based on deep convolutional neural networking is able to outperform average dermatologist. Further research is necessary to validate the performance of this method in the real world and in the clinical setting

COVID-19 and psoriasis: Is it time to limit treatment with immunosuppressants? A call for action

N/

HITLESS GRACEFUL INSERTION AND REMOVAL OF A ROUTER/SWITCH IN HIGHLY RELIABLE MULTICAST NETWORKS

Currently, the support for graceful insertion and removal (GIR) within a Protocol-Independent Multicast (PIM) environment is limited. As a result, there is no mechanism today that allows for a soft migration of flows when, for example, planning for a maintenance window. Techniques are presented herein that support a hitless upgrade capability that avoids impacting any flow during the upgrade and reload of a spine switch. This is the most difficult task today for customer networks, where multicast flows run all of the time and no disruption is acceptable. Aspects of the presented techniques include a new PIM hello message type-length-value (TLV) option. Such an option may be referred to herein as a progressive graceful insertion and removal (PGIR) capability option

Use of noninvasive imaging in the management of skin cancer

6Purpose of review: To evaluate noninvasive imaging techniques in the management of skin cancers. Recent findings: In the last decades, a wide range of noninvasive imaging methods has been developed in the field of dermatooncology with the aim to detect and assess the several structural and molecular changes that characterize skin cancer development and progression. Summary: In this review, we discuss the current and emerging applications of noninvasive imaging approaches in skin cancer management, such as digital photography, dermoscopy, ultrasound sonography, reflectance confocal microscopy, optical coherence tomography, electrical impedance techniques, Raman spectroscopy, multispectral imaging, fluorescence imaging, and multispectral optoacustic tomography.partially_openopenGiuffrida, Roberta; Conforti, Claudio; Di Meo, Nicola; Deinlein, Teresa; Guida, Stefania; Zalaudek, IrisGiuffrida, Roberta; Conforti, Claudio; Di Meo, Nicola; Deinlein, Teresa; Guida, Stefania; Zalaudek, Iri

Gene Therapy for Mitochondrial Diseases: Current Status and Future Perspective

Mitochondrial diseases (MDs) are a group of severe genetic disorders caused by mutations in the nuclear or mitochondrial genome encoding proteins involved in the oxidative phosphorylation (OXPHOS) system. MDs have a wide range of symptoms, ranging from organ-specific to multisystemic dysfunctions, with different clinical outcomes. The lack of natural history information, the limits of currently available preclinical models, and the wide range of phenotypic presentations seen in MD patients have all hampered the development of effective therapies. The growing number of pre-clinical and clinical trials over the last decade has shown that gene therapy is a viable precision medicine option for treating MD. However, several obstacles must be overcome, including vector design, targeted tissue tropism and efficient delivery, transgene expression, and immunotoxicity. This manuscript offers a comprehensive overview of the state of the art of gene therapy in MD, addressing the main challenges, the most feasible solutions, and the future perspectives of the field